Nwokoye Nkiru, Ihesie Austin, Olabamiji Jamiu, Ochei Kingsley, Eneogu Rupert, Umoren Michael, Odola Femi, Nongo Debby, Agbaje Aderonke, Odume Bethrand, Oyelaran Omosalewa, van Germert Wayne, Mupfumi Lucy, Emeka Elom, Anyaike Chukwuma, Scalise Sarah Cook, Ossai Edmund Ndudi
KNCV Nigeria, Abuja, Nigeria.
HIV AIDS & TB Office, USAID Nigeria, Abuja, Nigeria.
PLoS One. 2024 Dec 30;19(12):e0316204. doi: 10.1371/journal.pone.0316204. eCollection 2024.
World Health Organization in the year 2020 recommended the use of Truenat as a replacement for smear microscopy in Tuberculosis (TB) diagnosis and detection of rifampicin resistance. This study was designed to assess enablers and barriers to effective implementation of Truenat assays for TB diagnosis in Nigeria and determine the acceptability of use of Truenat among healthcare workers and TB Program managers in Nigeria.
A descriptive exploratory study design was used. Qualitative data were collected via Zoom platform using a pre-tested focus group discussion (FGD) guide and key informant interview (KII) guide. Four FGDs were conducted among Truenat laboratory staff, State Quality Assurance Officers, Local Government Tuberculosis Supervisors and Clinicians working at Truenat sites. Three KIIs were conducted among laboratory leads of Truenat implementing partners and the National TB Control Program.
All the participants attested to the reliability and acceptability of Truenat results, they also highlighted the portability and ease-of-use especially for community outreach testing. Stakeholder engagement, training of Truenat laboratory staff and the perceived low operational cost associated with Truenat were the enablers of Truenat implementation. Major barriers to the implementation included human resource for health constraints, lack of power supply, frequent Trueprep breakdown and Truenat machine connectivity. The same human resource constraint was viewed as the major barrier to scale up of Truenat while employment and retention of Truenat staff coupled with training were seen as the facilitators to scale-up. The participants implored the manufacturers of Truenat to increase the number of modules for Truenat, enable the use of stool for diagnosis of TB and attach a solar panel to the machine.
Truenat has gained high acceptance among health workers and TB Program managers in Nigeria. The perceived low operational cost and low infrastructural requirements have been a major boost. There is a need to ensure the retention of health workers especially the Truenat laboratory staff. Training should be sustained including the payment of incentives. Increasing the number of modules of the Truenat machine, enabling the use of stool for TB diagnosis and having a solar panel attached to Truenat machine are essential.
世界卫生组织在2020年建议使用TrueNat替代涂片显微镜检查来诊断结核病(TB)并检测利福平耐药性。本研究旨在评估尼日利亚有效实施TrueNat检测用于结核病诊断的促进因素和障碍,并确定尼日利亚医护人员和结核病项目管理人员对使用TrueNat的接受程度。
采用描述性探索性研究设计。通过Zoom平台,使用预先测试的焦点小组讨论(FGD)指南和关键 informant 访谈(KII)指南收集定性数据。在TrueNat实验室工作人员、州质量保证官员、地方政府结核病监督员以及在TrueNat站点工作的临床医生中进行了四次FGD。在TrueNat实施伙伴的实验室负责人和国家结核病控制项目中进行了三次KII。
所有参与者都证明了TrueNat结果的可靠性和可接受性,他们还强调了其便携性和易用性,特别是对于社区外展检测。利益相关者的参与、TrueNat实验室工作人员的培训以及与TrueNat相关的较低运营成本被认为是TrueNat实施的促进因素。实施的主要障碍包括卫生人力资源限制、电力供应不足、TruePrep频繁故障以及TrueNat机器连接问题。同样的人力资源限制被视为扩大TrueNat规模的主要障碍,而TrueNat工作人员的招聘和留用以及培训则被视为扩大规模的促进因素。参与者恳请TrueNat制造商增加TrueNat的模块数量,允许使用粪便进行结核病诊断,并在机器上安装太阳能板。
TrueNat在尼日利亚的医护人员和结核病项目管理人员中获得了高度认可。较低的运营成本和基础设施要求被认为是一个主要推动因素。有必要确保医护人员尤其是TrueNat实验室工作人员的留用。应持续进行培训,包括支付激励措施。增加TrueNat机器的模块数量、允许使用粪便进行结核病诊断以及在TrueNat机器上安装太阳能板至关重要。